SUMOylation is a post-translational modification essential to cell homeostasis. A tightly controlled equilibrium between SUMOylation and deSUMOylation processes is also critical to the neuronal function including neurotransmitter release and synaptic transmission and plasticity. Disruption of the SUMOylation homeostasis in neurons is associated with several neurological disorders. The balance between the SUMOylation and deSUMOylation of substrate proteins is maintained by a group of deSUMOylation enzymes called SENPs. We previously showed that the activation of type 5 metabotropic glutamate receptors (mGlu5R) first triggers a rapid increase in synaptic SUMOylation and then upon the sustained activation of these receptors, the deSUMOylase activity of SENP1 allows the increased synaptic SUMOylation to get back to basal levels. Here, we combined the use of pharmacological tools with subcellular fractionation and live-cell imaging of individual hippocampal dendritic spines to demonstrate that the synaptic accumulation of the deSUMOylation enzyme SENP1 is bidirectionally controlled by the activation of type 1 mGlu1 and mGlu5 receptors. Indeed, the pharmacological blockade of mGlu1R activation during type 1 mGluR stimulation leads to a faster and greater accumulation of SENP1 at synapses indicating that mGlu1R acts as a brake to the mGlu5R-dependent deSUMOylation process at the post-synapse. Altogether, our findings reveal that type 1 mGluRs work in opposition to dynamically tune the homeostasis of SUMOylation at the mammalian synapse.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226087PMC
http://dx.doi.org/10.1007/s00018-022-04405-zDOI Listing

Publication Analysis

Top Keywords

synaptic sumoylation
12
activation type
12
sumoylation
8
metabotropic glutamate
8
glutamate receptors
8
sumoylation desumoylation
8
synaptic
5
desumoylation
5
bidirectional regulation
4
regulation synaptic
4

Similar Publications

Alzheimer's disease (AD) is a neurodegenerative disease, which is mainly characterized by the abnormal deposition of β-amyloid peptide (Aβ) and Tau. Since Tau aggregation is more closely associated with synaptic loss, neurodegeneration, and cognitive decline than Aβ, the correlation between Tau and cognitive function in AD has gradually gained attention. The posttranslational modifications (PTMs) of Tau are key factors contributing to its pathological changes, which include phosphorylation, acetylation, ubiquitination, glycosylation, glycation, small ubiquitin-like modifier mediated modification (SUMOylation), methylation, succinylation, etc.

View Article and Find Full Text PDF
Article Synopsis
  • Multiple sclerosis (MS) is a common neurodegenerative disease that leads to damage in the central nervous system, and its mechanisms are still being investigated using the EAE mouse model.
  • In a recent study, researchers identified 744 proteins that change in the brain and 741 in the spinal cord of EAE mice, linking these proteins to processes like phagocytosis and inflammasome activation.
  • The study also revealed that targeting SUMOylation, a process modified by a selective inhibitor called TAK-981, can reduce MS symptoms and provide insights for potential new treatments.
View Article and Find Full Text PDF

N6 adenosine and C5 cytosine modification of mRNAs, tRNAs and rRNAs are regulated by the behaviour of distinct sets of writer, reader and eraser effector proteins which are conventionally considered to function independently. Here, we provide evidence of global cross-regulatory and functional interaction between the mA and mC RNA methylation systems. We first show that mA and mC effector protein transcripts are subject to reciprocal base modification supporting the existence of co-regulatory post-transcriptional feedback loops.

View Article and Find Full Text PDF

Hippocampal SENP3 mediates chronic stress-induced depression-like behaviors by impairing the CREB-BDNF signaling.

Neuropharmacology

January 2025

Department of Pharmacology, School of Pharmacy, Nantong University, #19 Qixiu Road, Nantong 226001, Jiangsu Province, China. Electronic address:

Impaired signaling between cyclic adenosine monophosphate response element binding protein (CREB) and brain-derived neurotrophic factor (BDNF) in the hippocampus is generally considered to be the cause of depression. The mechanisms underlying the impairment of CREB-BDNF signaling under stress conditions are largely unclear. Small ubiquitin-like modifier (SUMO) specific peptidase 3 (SENP3) is a molecule that can regulate SUMOylation of target proteins related to synaptic plasticity.

View Article and Find Full Text PDF
Article Synopsis
  • Huntington's disease (HD) is linked to a mutation in the Huntingtin gene that disrupts normal brain function, and the study investigates how SUMOylation affects proteins involved in neuronal activity in HD mice.* -
  • Using advanced mass spectrometry, researchers found changes in SUMOylated proteins related to synaptic function and signaling pathways in HD tissue, which were different from non-transgenic mice.* -
  • Experiments on neurons from HD and control mice revealed that altering SUMOylation, particularly via the Pias1 protein, can improve signaling and activity deficits observed in HD cells.*
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!